So far, the pro-cancerous activity of AKAP9 has been extensively studied in colorectal cancer [36,37], gastric cancer [38], and acute myeloid leukaemia [39], where its action was related to cancer cell proliferation, migration, and invasion [32], as well as lower survival [37]. Here, AKAP9 is linked to cancer.